Cell Growth & Differentiation, Vol 9, Issue 10 847-855, Copyright © 1998 by American Association of Cancer Research

ARTICLES

STAT3 activation accompanies keratinocyte differentiation

PJ Hauser, D Agrawal, J Hackney and WJ Pledger
Department of Cell Biology, Vanderbilt University, Nashville, Tennessee 37240, USA.

The signal transducers and activators of transcription (STAT) family of transcription factors has been demonstrated to play key roles in a variety of cell types under conditions that promote differentiation or cell cycle exit. We report our studies of primary murine keratinocytes in which we demonstrate activation of STAT3 during growth arrest and differentiation. In adherent cells, STAT3-specific DNA binding activity was detected in quiescent cultures, down-regulated upon mitogenic stimulation, and found to reaccumulate as cells reentered quiescence. Suspension culturing of proliferating keratinocytes, which induces differentiation, also resulted in induction of STAT3 activity. Furthermore, induction of STAT3 after suspension culturing did not occur in MK cells, an immortalized murine keratinocyte cell line that does not undergo differentiation. Because STAT3 activation in these cells corresponded tightly with the growth status, we examined whether there was a relationship between the cell cycle machinery and STAT3 activation by inhibiting p27kip1 accumulation, which is observed during growth arrest, with antisense oligonucleotides and by using keratinocytes lacking functional p27kip1. In both cases, there was a loss of STAT3 activation and a concomitant delay in terminal cell cycle withdrawal and in the expression of the differentiation specific marker, keratin 1. Thus, in addition to controlling transcription mediated through E2F, our data demonstrate that alterations in the cell cycle machinery are required for appropriate up-regulation of STAT3 activity that occurs during keratinocyte differentiation.

This article has been cited by other articles:

				M. C. Simeone-Penney, M. Severgnini, L. Rozo, S. Takahashi, B. H. Cochran, and A. R. Simon PDGF-induced human airway smooth muscle cell proliferation requires STAT3 and the small GTPase Rac1 Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L698 - L704. [Abstract] [Full Text] [PDF]

				H.-W. Su, H.-H. Yeh, S.-W. Wang, M.-R. Shen, T.-L. Chen, P. R. Kiela, F. K. Ghishan, and M.-J. Tang Cell Confluence-induced Activation of Signal Transducer and Activator of Transcription-3 (Stat3) Triggers Epithelial Dome Formation via Augmentation of Sodium Hydrogen Exchanger-3 (NHE3) Expression J. Biol. Chem., March 30, 2007; 282(13): 9883 - 9894. [Abstract] [Full Text] [PDF]

				K. S. Chan, S. Carbajal, K. Kiguchi, J. Clifford, S. Sano, and J. DiGiovanni Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis Cancer Res., April 1, 2004; 64(7): 2382 - 2389. [Abstract] [Full Text] [PDF]

				P. Hauser, L. Ma, D. Agrawal, E. Haura, W. D. Cress, and W. J. Pledger Efficient Down-Regulation of Cyclin A-Associated Activity and Expression in Suspended Primary Keratinocytes Requires p21Cip1 Mol. Cancer Res., February 1, 2004; 2(2): 96 - 104. [Abstract] [Full Text] [PDF]

				M. Taler, S. Shpungin, Y. Salem, H. Malovani, O. Pasder, and U. Nir Fer Is a Downstream Effector of Insulin and Mediates the Activation of Signal Transducer and Activator of Transcription 3 in Myogenic Cells Mol. Endocrinol., August 1, 2003; 17(8): 1580 - 1592. [Abstract] [Full Text] [PDF]

				J. Albanell, F. Rojo, S. Averbuch, A. Feyereislova, J. M. Mascaro, R. Herbst, P. LoRusso, D. Rischin, S. Sauleda, J. Gee, et al. Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor Inhibition J. Clin. Oncol., January 1, 2002; 20(1): 110 - 124. [Abstract] [Full Text] [PDF]

				R. M. GALLUCCI, P. P. SIMEONOVA, J. M. MATHESON, C. KOMMINENI, J. L. GURIEL, T. SUGAWARA, and M. I. LUSTER Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice FASEB J, December 1, 2000; 14(15): 2525 - 2531. [Abstract] [Full Text]

				J. L. Clifford, D. G. Menter, X. Yang, E. Walch, C. Zou, G. L. Clayman, T. S. Schaefer, A. K. El-Naggar, R. Lotan, and S. M. Lippman Expression of Protein Mediators of Type I Interferon Signaling in Human Squamous Cell Carcinoma of the Skin Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 993 - 997. [Abstract] [Full Text]

				M. Jost, T. M. Huggett, C. Kari, L. H. Boise, and U. Rodeck Epidermal Growth Factor Receptor-dependent Control of Keratinocyte Survival and Bcl-xL Expression through a MEK-dependent Pathway J. Biol. Chem., February 23, 2001; 276(9): 6320 - 6326. [Abstract] [Full Text] [PDF]